BRCA1/BARD1 orthologs required for DNA repair in Caenorhabditis elegans

被引:121
作者
Boulton, SJ [1 ]
Martin, JS
Polanowska, J
Hill, DE
Gartner, A
Vidal, M
机构
[1] London Res Inst, Canc Res UK, Clare Hall Labs, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[4] Max Planck Inst Biochem, D-82152 Martinsried, Germany
关键词
D O I
10.1016/j.cub.2003.11.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inherited germline mutations in the tumor suppressor gene BRCA1 predispose individuals to early onset breast and ovarian cancer [1]. BRCA1 together with its structurally related partner BARD1 is required for homologous recombination and DNA double-strand break repair, but how they perform these functions remains elusive [2, 3]. As part of a comprehensive search for DNA repair genes in C. elegans, we identified a BARD1 ortholog. In protein interaction screens, Ce-BRD-1 was found to interact with components of the sumoylation pathway, the TACC domain protein TAC-1, and most importantly, a homolog of mammalian BRCA1. We show that animals depleted for either Ce-brc-1 or Ce-brd-1 display similar abnormalities, including a high incidence of males, elevated levels of p53-dependent germ cell death before and after irradiation, and impaired progeny survival and chromosome fragmentation after irradiation. Furthermore, depletion of ubc-9 and tac-1 leads to radiation sensitivity and a high incidence of males, respectively, potentially linking these genes to the C. elegans BRCA1 pathway. Our findings support a shared role for Ce-BRC-1 and Ce-BRD-1 in C. elegans DNA repair processes, and this role will permit studies of the BRCA1 pathway in an organism amenable to rapid genetic and biochemical analysis.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 34 条
  • [1] C-elegans RAD-5/CLK-2 defines a new DNA damage checkpoint protein
    Ahmed, S
    Alpi, A
    Hengartner, MO
    Gartner, A
    [J]. CURRENT BIOLOGY, 2001, 11 (24) : 1934 - 1944
  • [2] The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity
    Baer, R
    Ludwig, T
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (01) : 86 - 91
  • [3] Combined functional genomic maps of the C-elegans DNA damage response
    Boulton, SJ
    Gartner, A
    Reboul, J
    Vaglio, P
    Dyson, N
    Hill, DE
    Vidal, M
    [J]. SCIENCE, 2002, 295 (5552) : 127 - 131
  • [4] BRENNER S, 1974, GENETICS, V77, P71
  • [5] Structure of a BRCA1-BARD1 heterodimeric RING-RING complex
    Brzovic, PS
    Rajagopal, P
    Hoyt, DW
    King, MC
    Klevit, RE
    [J]. NATURE STRUCTURAL BIOLOGY, 2001, 8 (10) : 833 - 837
  • [6] Autoubiquitination of the BRCA1-BARD1 RING ubiquitin ligase
    Chen, A
    Kleiman, FE
    Manley, JL
    Ouchi, T
    Pan, ZQ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) : 22085 - 22092
  • [7] AZU-1:: A candidate breast tumor suppressor and biomarker for tumor progression
    Chen, HM
    Schmeichel, KL
    Mian, IS
    Lelièvre, S
    Petersen, OW
    Bissell, MJ
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (04) : 1357 - 1367
  • [8] Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
    Chen, JJ
    Silver, DP
    Walpita, D
    Cantor, SB
    Gazdar, AF
    Tomlinson, G
    Couch, FJ
    Weber, BL
    Ashley, T
    Livingston, DM
    Scully, R
    [J]. MOLECULAR CELL, 1998, 2 (03) : 317 - 328
  • [9] Chen YM, 1999, J CELL PHYSIOL, V181, P385, DOI 10.1002/(SICI)1097-4652(199912)181:3<385::AID-JCP2>3.0.CO
  • [10] 2-4